Silent beta-thalassemia and thalassemia intermedia

Heterozygosity for the IVS-I-5 (G-->C) mutation with a G-->A change at codon 18 (Val-->Met; Hb Baden) in cis and a T-->G mutation at codon 126 (Val-->Gly; Hb Dhonburi) in trans resulting in a thalassemia intermedia.

Biochimica et biophysica acta·1992

Clinical, hematological, and molecular features in Sicilians with Hb S-beta-thalassemia.

American journal of hematology·1992

Molecular characterization of beta-thalassemia in Azerbaijan.

Human genetics·1992

Black beta-thalassemia homozygotes with specific sequence variations in the 5' hypersensitive site-2 of the locus control region have high levels of fetal hemoglobin.

American journal of hematology·1992

Heterogeneity of the hemoglobin of the Ohrid trout (Salmo L. typicus).

Biochemical genetics·1992

Haplotypes in SS patients from Nigeria; characterization of one atypical beta S haplotype no. 19 (Benin) associated with elevated HB F and high G gamma levels.

Annals of hematology·1992

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

Haematologica·2026

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Haematologica·2026

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Haematologica·2026

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Haematologica·2026

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

Haematologica·2026

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

Haematologica·2026

World Humanitarian Day: Why humanitarian settings need more research, not less.

PLoS medicine·2026

Not All Red Flags Indicate Malignancy: A Case Report of a Benign Lipoma Mimicking Soft-tissue Sarcoma.

Journal of orthopaedic case reports·2026

Beyond the treatment episode: Closing gaps across the continuum of care.

The Medical journal of Malaysia·2026

Hospital Responses to New Disproportionate Share Payment Rules.

Health services research·2026

Postimplementation evaluation of cytopathology amendment reports after adoption of a new laboratory information system: identifying diagnostic, reporting, and workflow challenges.

Journal of the American Society of Cytopathology·2026

Evaluating the Accessibility of Online Resources Regarding Biceps Tenodesis.

The Journal of the American Academy of Orthopaedic Surgeons·2026

Related Experiment Videos

Silent beta-thalassemia and thalassemia intermedia

Related Concept Videos

Heterozygosity for the IVS-I-5 (G-->C) mutation with a G-->A change at codon 18 (Val-->Met; Hb Baden) in cis and a T-->G mutation at codon 126 (Val-->Gly; Hb Dhonburi) in trans resulting in a thalassemia intermedia.

Clinical, hematological, and molecular features in Sicilians with Hb S-beta-thalassemia.

Molecular characterization of beta-thalassemia in Azerbaijan.

Black beta-thalassemia homozygotes with specific sequence variations in the 5' hypersensitive site-2 of the locus control region have high levels of fetal hemoglobin.

Heterogeneity of the hemoglobin of the Ohrid trout (Salmo L. typicus).

Haplotypes in SS patients from Nigeria; characterization of one atypical beta S haplotype no. 19 (Benin) associated with elevated HB F and high G gamma levels.

Genetic thrombophilia in cancer-associated thrombosis: the fly plowing with the ox or an old player's new role?

From prognostic discrimination to clinical utility in high-risk myeloma. Comment on: "Risk factors and their contributions to prognosis in multiple myeloma".

Learning from relapse: how MajesTEC-1 immune profiling points the way to next-generation bispecific strategies.

Making remissions last: the promise of maintenance in primary central nervous system lymphoma.

Venetoclax combined with high-dose cytarabine and mitoxantrone for relapsed or refractory acute myeloid leukemia: outcomes and risk stratification.

The many faces (and phenotypes) of BCR::ABL1-driven acute leukemia.

World Humanitarian Day: Why humanitarian settings need more research, not less.

Not All Red Flags Indicate Malignancy: A Case Report of a Benign Lipoma Mimicking Soft-tissue Sarcoma.

Beyond the treatment episode: Closing gaps across the continuum of care.

Hospital Responses to New Disproportionate Share Payment Rules.

Postimplementation evaluation of cytopathology amendment reports after adoption of a new laboratory information system: identifying diagnostic, reporting, and workflow challenges.

Evaluating the Accessibility of Online Resources Regarding Biceps Tenodesis.

Related Experiment Videos

Silent beta-thalassemia and thalassemia intermedia

Related Concept Videos

Related Articles